Ionis Pharmaceuticals Inc banner

Ionis Pharmaceuticals Inc
SWB:ISI

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
SWB:ISI
Watchlist
Price: 38.64 EUR -2.42% Market Closed
Market Cap: €5.5B

Wall St Price Targets

ISI Price Forecast
Based on 24 analysts

+94% Upside
from €38.64 today

ISI Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ISI yet.

Ionis Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

19% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
19% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.

Gross Profit
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat

The compound annual growth rate for Gross Profit over the next 8 years is 24%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ISI's stock price target?
Price Target
74.91 EUR

According to Wall Street analysts, the average 1-year price target for ISI is 74.91 EUR with a low forecast of 47.13 EUR and a high forecast of 95.26 EUR.

What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.

What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Gross Profit over the next 8 years is 24%.

Back to Top